NMNAT3 is protective against the effects of neonatal cerebral hypoxia‐ischemia
Rafael Galindo(Hope Center for Neurological Disorders), David M. Holtzman(Hope Center for Neurological Disorders), Jeffrey Milbrandt(James S. McDonnell Foundation), Toshiyuki Araki(National Center of Neurology and Psychiatry), M. Banks Greenberg(Hope Center for Neurological Disorders), Yo Sasaki(SHOWA Medical University), Nehali Mehta(Hope Center for Neurological Disorders)
Cited by 22
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k